CVE-2026-60172 Oracle CVE debrief

Who should care

Oracle Autonomous Health Framework administrators, Security teams managing Oracle infrastructure, IT personnel responsible for applying patches and mitigations, and operators of affected systems should be aware of this vulnerability and take necessary actions to protect their infrastructure. This includes reviewing and applying patches or mitigations as recommended by Oracle, monitoring for suspicious activity, and restricting access to infrastructure where Oracle Autonomous Health Framework executes. Additionally, security teams should prioritize patching and mitigation efforts based on the medium severity of this vulnerability and the potential impact on their organization's security posture. Affected product deployments should be identified and assigned an owner for follow-up to ensure timely remediation. Compensating controls should be reviewed and implemented for exposed systems while remediation is scheduled and verified. Relevant monitoring, detection, and logs should be checked for exposed assets that need extra review. Exceptions should be tracked, and remediated assets should be retested and closed only after evidence is documented. The CVE record and vendor advisory should be reviewed to validate affected scope, severity, and vendor guidance. Vendor-supported updates or mitigations should be planned through normal change control where exposure is confirmed. Source grounding and evidence limits should be considered when evaluating this vulnerability and implementing defensive measures. Defenders should verify the affected scope and implement necessary controls to prevent exploitation. The vulnerability requires high privileges and human interaction for exploitation, which can result in takeover of Oracle Autonomous Health Framework. Successful attacks can have significant impacts on confidentiality, integrity, and availability. Therefore, it is essential to prioritize patching and mitigation efforts to prevent potential security breaches. The CVSS 3.1 Base Score of 6.3 indicates medium severity, and the CVSS Vector is (CVSS:3.1/AV:L/AC:H/PR:H/UI:R/S:U/C:H/I:H/A:H). The vulnerability allows high privileged attackers with logon to the infrastructure to

Technical summary

The CVE-2026-60172 vulnerability is a difficult-to-exploit issue in Oracle Autonomous Health Framework that allows high privileged attackers with logon to the infrastructure to compromise the framework. Successful attacks require human interaction from a person other than the attacker and can result in takeover of Oracle Autonomous Health Framework. The vulnerability has a CVSS 3.1 Base Score of 6.3, indicating medium severity.

Defensive priority

Medium severity vulnerability in Oracle Autonomous Health Framework requires high privileges and human interaction for exploitation.

Recommended defensive actions

• Inventory and verify Oracle Autonomous Health Framework versions 26.0.0, 26.1.0, and 26.2.0 for exposure
• Apply vendor patches or mitigations as recommended by Oracle
• Monitor for suspicious activity requiring high privileges and human interaction
• Restrict access to infrastructure where Oracle Autonomous Health Framework executes
• Implement compensating controls for sensitive operations

Evidence notes

The CVE-2026-60172 vulnerability affects Oracle Autonomous Health Framework versions 26.0.0, 26.1.0, and 26.2.0. It is a difficult-to-exploit vulnerability that allows high privileged attackers with logon to the infrastructure to compromise the framework. Successful attacks require human interaction and can result in takeover of Oracle Autonomous Health Framework.

Official resources